175 related articles for article (PubMed ID: 27901027)
1. Targeted killing of myofibroblasts by biosurfactant di-rhamnolipid suggests a therapy against scar formation.
Shen C; Jiang L; Shao H; You C; Zhang G; Ding S; Bian T; Han C; Meng Q
Sci Rep; 2016 Nov; 6():37553. PubMed ID: 27901027
[TBL] [Abstract][Full Text] [Related]
2. Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring.
Li Y; Shi S; Gao J; Han S; Wu X; Jia Y; Su L; Shi J; Hu D
Biomed Pharmacother; 2016 May; 80():80-86. PubMed ID: 27133042
[TBL] [Abstract][Full Text] [Related]
3. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
4. miR-145 Contributes to Hypertrophic Scarring of the Skin by Inducing Myofibroblast Activity.
Gras C; Ratuszny D; Hadamitzky C; Zhang H; Blasczyk R; Figueiredo C
Mol Med; 2015 Apr; 21(1):296-304. PubMed ID: 25876136
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts.
Wells AR; Leung KP
Biochem Biophys Res Commun; 2020 Jan; 521(3):646-651. PubMed ID: 31679692
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of electron transfer flavoprotein β subunit reduced TGF-β-induced α-SMA mRNA expression but not COL1A1 in fibroblast-populated three-dimensional collagen gel cultures.
Hirokawa S; Shimanuki T; Kitajima H; Nishimori Y; Shimosaka M
J Dermatol Sci; 2012 Dec; 68(3):179-86. PubMed ID: 23068445
[TBL] [Abstract][Full Text] [Related]
7. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
Chawla S; Ghosh S
Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
[TBL] [Abstract][Full Text] [Related]
8. The role of ERK and JNK signaling in connective tissue growth factor induced extracellular matrix protein production and scar formation.
Hu X; Wang H; Liu J; Fang X; Tao K; Wang Y; Li N; Shi J; Wang Y; Ji P; Cai W; Bai X; Zhu X; Han J; Hu D
Arch Dermatol Res; 2013 Jul; 305(5):433-45. PubMed ID: 23494140
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway.
Li Y; Zhang W; Gao J; Liu J; Wang H; Li J; Yang X; He T; Guan H; Zheng Z; Han S; Dong M; Han J; Shi J; Hu D
Stem Cell Res Ther; 2016 Aug; 7(1):102. PubMed ID: 27484727
[TBL] [Abstract][Full Text] [Related]
10. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal shock wave therapy with low-energy flux density inhibits hypertrophic scar formation in an animal model.
Zhao JC; Zhang BR; Hong L; Shi K; Wu WW; Yu JA
Int J Mol Med; 2018 Apr; 41(4):1931-1938. PubMed ID: 29393337
[TBL] [Abstract][Full Text] [Related]
12. Liposome-encapsulated statins reduce hypertrophic scarring through topical application.
Xie P; Dolivo DM; Jia S; Cheng X; Salcido J; Galiano RD; Hong SJ; Mustoe TA
Wound Repair Regen; 2020 Jul; 28(4):460-469. PubMed ID: 32428986
[TBL] [Abstract][Full Text] [Related]
13. Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway.
Li Y; Zhang J; Zhou Q; Wang H; Xie S; Yang X; Ji P; Zhang W; He T; Liu Y; Wang K; Li X; Shi J; Hu D
Exp Dermatol; 2019 Jan; 28(1):19-27. PubMed ID: 30308704
[TBL] [Abstract][Full Text] [Related]
14. Effects of DMSO on a rabbit ear hypertrophic scar model: A controlled randomized experimental study.
Sari E; Bakar B; Dincel GC; Budak Yildiran FA
J Plast Reconstr Aesthet Surg; 2017 Apr; 70(4):509-517. PubMed ID: 28216321
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1.
Li Y; Zhang J; Zhang W; Liu Y; Li Y; Wang K; Zhang Y; Yang C; Li X; Shi J; Su L; Hu D
J Mol Histol; 2017 Dec; 48(5-6):357-366. PubMed ID: 28884252
[TBL] [Abstract][Full Text] [Related]
16. Effect of Keratinocytes on Myofibroblasts in Hypertrophic Scars.
Lee JS; Kim JS; Lee JW; Choi KY; Yang JD; Cho BC; Oh EJ; Kim TJ; Ko UH; Shin JH; Jeon S; Lee YJ; Chung HY
Aesthetic Plast Surg; 2019 Oct; 43(5):1371-1380. PubMed ID: 31346713
[TBL] [Abstract][Full Text] [Related]
17. Use of ginsenoside Rg3-loaded electrospun PLGA fibrous membranes as wound cover induces healing and inhibits hypertrophic scar formation of the skin.
Sun X; Cheng L; Zhu W; Hu C; Jin R; Sun B; Shi Y; Zhang Y; Cui W
Colloids Surf B Biointerfaces; 2014 Mar; 115():61-70. PubMed ID: 24333554
[TBL] [Abstract][Full Text] [Related]
18. [Role of p38 mitogen activated protein kinase on cyclic stretch in human facial hypertrophic scar fibroblasts differentiation into myofibroblasts].
Du QC; Xiao WL; Xue LF; Wang SY; Yue J; Xu YX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Oct; 48(10):615-20. PubMed ID: 24438570
[TBL] [Abstract][Full Text] [Related]
19. Role of miR-145 in cardiac myofibroblast differentiation.
Wang YS; Li SH; Guo J; Mihic A; Wu J; Sun L; Davis K; Weisel RD; Li RK
J Mol Cell Cardiol; 2014 Jan; 66():94-105. PubMed ID: 24001939
[TBL] [Abstract][Full Text] [Related]
20. Extensive CD34-to-CD90 Fibroblast Transition Defines Regions of Cutaneous Reparative, Hypertrophic, and Keloidal Scarring.
Ho JD; Chung HJ; Ms Barron A; Ho DA; Sahni D; Browning JL; Bhawan J
Am J Dermatopathol; 2019 Jan; 41(1):16-28. PubMed ID: 30320623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
